Evidence map›Paper›PMID 32924006›Full record

ArticleMaterials today. Bio2020

Engineering osteogenic microenvironments by combination of multilayers from collagen type I and chondroitin sulfate with novel cationic liposomes.

Y A Brito Barrera, G Hause, M Menzel, C E H Schmelzer, E Lehner, K Mäder, C Wölk, T Groth

Open access · goldAbstract read
In one paragraph

Article in Materials today. Bio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Encapsulated vaterite-calcite CaCOFrontiers in bioengineering and biotechnology · 2022
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Y A Brito BarreraDepartment Biomedical Materials, Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Heinrich Damerow Strasse 4, 06120, Halle (Saale), Germany.
G HauseMartin Luther University Halle-Wittenberg, Biocenter, Weinbergweg 22, 06120, Halle (Saale), Germany.
M MenzelDepartment of Biological and Macromolecular Materials, Fraunhofer Institute for Microstructure of Materials and Systems (IMWS), Walter-Hülse-Strasse 1, 06120, Halle (Saale), Germany.
C E H SchmelzerDepartment of Biological and Macromolecular Materials, Fraunhofer Institute for Microstructure of Materials and Systems (IMWS), Walter-Hülse-Strasse 1, 06120, Halle (Saale), Germany.
E LehnerDepartment Pharmaceutical Technology, Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Kurt-Mothes Straße 3, 06120, Halle (Saale), Germany.
K MäderDepartment Pharmaceutical Technology, Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Kurt-Mothes Straße 3, 06120, Halle (Saale), Germany.
C WölkPharmaceutical Technology, Institute of Pharmacy, Faculty of Medicine, Leipzig University, 04317, Leipzig, Germany.
T GrothDepartment Biomedical Materials, Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Heinrich Damerow Strasse 4, 06120, Halle (Saale), Germany.
Martin Luther University Halle-Wittenberg · DEFraunhofer Institute for Microstructure of Materials and Systems · DELeipzig University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cationic liposomes composed of a novel lipid (N-{6-amino-1-[N-(9Z) -octadec9-enylamino] -1-oxohexan-(2S) -2-yl} -N'- {2- [N, N-bis(2-aminoethyl) amino] ethyl} -2-hexadecylpropandiamide) (OO4) and dioleoylphosphatidylethanolamine (DOPE) possess high amounts of amino groups and are promising systems for lipofection. Moreover, these cationic liposomes can also be used as a polycationic entity in multilayer formation using layer-by-layer technique (LbL), which is a method to fabricate surface coatings by alternating adsorption of polyanions and polycations. Since liposomes are suitable for endocytosis by or fusion with cells, controlled release of their cargo on site is possible. Here, a polyelectrolyte multilayer (PEM) system was designed of chondroitin sulfate (CS) and collagen type I (Col I) by LbL technique with OO4/DOPE liposomes embedded in the terminal layers to create an osteogenic microenvironment. Both, the composition of PEM and cargo of the liposomes were used to promote osteogenic differentiation of C2C12 myoblasts as in vitro model. The internalization of cargo-loaded liposomes from the PEM into C2C12 cells was studied using lipophilic (Rhodamine-DOPE conjugate) and hydrophilic (Texas Red-labeled dextran) model compounds. Besides, the use of Col I and CS should mimic the extracellular matrix of bone for future applications such as bone replacement therapies. Physicochemical studies of PEM were done to characterize the layer growth, thickness, and topography. The adhesion of myoblast cells was also evaluated whereby the benefit of a cover layer of CS and finally Col I above the liposome layer was demonstrated. As proof of concept, OO4/DOPE liposomes were loaded with dexamethasone, a compound that can induce osteogenic differentiation. A successful induction of osteogenic differentiation of C2C12 cells with the novel designed liposome-loaded PEM system was shown. These findings indicate that designed OH4/DOPE loaded PEMs have a high potential to be used as drug delivery or transfection system for implant coating in the field of bone regeneration and other applications.

Indexed as

AFM, Atomic force microscopyC2C12 myoblastscationic lipidschondroitin sulfateCLSM, Confocal Laser Scanning MicroscopyCol I, Collagen Icollagen ICS, chondroitin sulfateDex, DexamethasoneDLS, Dynamic light scatteringDMEM, Dulbecco’s modified Eagle’s mediumDOPE, dioleoylphosphatidylethanolamineECM, Extracellular matrixGAG, GlycosaminoglycaninternalizationLbL, Layer-by-Layer techniqueOO4, (N-{6-amino-1-[N-(9Z) -octadec9-enylamino] -1-oxohexan-(2S) -2-yl} -N’- {2- [N, N-bis(2-aminoethyl) amino] ethyl} -2-hexadecylpropandiamide)osteogenic differentiationPBS, Phosphate-buffered salinePEI, PolyethyleniminePEM, Polyelectrolyte multilayerpolyelectrolyte multilayer systemSEM, Scanning electron microscopySPR, Surface plasmon resonanceTEM, Transmission electron microscopyWCA, Water contact angle

Identifiers

PMID32924006
PMCPMC7476072
OpenAlexW3046698814

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.